These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26380128)

  • 1. B Cell Lymphoma, Unclassifiable, Transformed from Follicular Lymphoma: A Rare Presentation with Review of the Literature.
    Kanna A; Agrawal S; Jayant K; Kumar Pala V; Altujjar M; Hadid T; Khurram M
    Case Rep Hematol; 2015; 2015():651764. PubMed ID: 26380128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma without mediastinal disease: mimicking nodular sclerosis classical Hodgkin lymphoma.
    Iwaki N; Sato Y; Kurokawa T; Maeda Y; Ohno K; Takeuchi M; Takata K; Orita Y; Nakao S; Yoshino T
    Med Mol Morphol; 2013 Sep; 46(3):172-6. PubMed ID: 23512149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
    Bischin AM; Dorer R; Aboulafia DM
    Clin Med Insights Blood Disord; 2017; 10():1179545X17692544. PubMed ID: 28579851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
    Wang E; Papavassiliou P; Sebastian S
    Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: clinicopathologic characterization of 16 cases showing different patterns].
    Wang L; Wang W; Li X; Guo Y; Zhu X
    Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):307-12. PubMed ID: 25030862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gray zone lymphoma effectively treated with cyclophosphamide, doxorubicin, vincristine, prednisolone, and rituximab chemotherapy: A case report.
    Hojo N; Nagasaki M; Mihara Y
    World J Clin Cases; 2022 Jun; 10(17):5708-5716. PubMed ID: 35979119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD5-positive follicular lymphoma: a case report and literature review.
    Sekiguchi Y; Imai H; Wakabayashi M; Sawada T; Ichikawa K; Komatsu N; Noguchi M
    Intern Med; 2011; 50(8):899-904. PubMed ID: 21498939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of Immunocytochemistry to the Diagnosis of Usual and Unusual Lymphoma Cases.
    Das DK
    J Cytol; 2018; 35(3):163-169. PubMed ID: 30089946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and classical hodgkin lymphoma: diagnosis by fine-needle aspiration cytology.
    Lynnhtun K; Varikatt W; Pathmanathan N
    Diagn Cytopathol; 2014 Aug; 42(8):690-3. PubMed ID: 23630122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and Risk Factors of Infections Among Diffuse Large B-cell Lymphoma and Classical Hodgkin's Lymphoma Patients in a Tertiary Care Center in Saudi Arabia: A Retrospective Cohort Study.
    Alelyani RH; Alghamdi AH; Almughamisi TA; Alshareef AM; Kadasa AN; Alrajhi AM; Alburayk AK; Barefah AS; Radhwi OO; Almohammadi AT; Bahashawan SM; AlAhwal HM
    Cureus; 2023 Mar; 15(3):e35922. PubMed ID: 36911585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary splenic B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: A case report.
    Shi F; Zhou Q; Gao Y; Cui XQ; Chang H
    Oncol Lett; 2016 Sep; 12(3):1925-1928. PubMed ID: 27602118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma.
    Traverse-Glehen A; Pittaluga S; Gaulard P; Sorbara L; Alonso MA; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2005 Nov; 29(11):1411-21. PubMed ID: 16224207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unraveling the Mystery of Gray Zone Lymphoma in Human Immunodeficiency Virus-Seropositive Patients: Two Cases.
    Ahluwalia A; Bondili L; Salamera J; Cholankeril M
    J Hematol; 2020 Dec; 9(4):132-136. PubMed ID: 33224393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of Combined EZH2, p-ERK1/2, p-STAT, and MYC Expression in the Differential Diagnosis of EZH2-positive Hodgkin Lymphomas and Related Large B-Cell Lymphomas.
    Tian X; Xu J; Dorfman DM
    Am J Surg Pathol; 2019 Jan; 43(1):102-109. PubMed ID: 30371509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Rare Case of Diffuse Large B Cell Lymphoma Presenting as a Cardiac Mass.
    Yousif P; Kotecha A; Thakur A; Ismail HM
    Am J Case Rep; 2019 Dec; 20():1821-1825. PubMed ID: 31809493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BOB.1, CD79a and cyclin E are the most appropriate markers to discriminate classical Hodgkin's lymphoma from primary mediastinal large B-cell lymphoma.
    Hoeller S; Zihler D; Zlobec I; Obermann EC; Pileri SA; Dirnhofer S; Tzankov A
    Histopathology; 2010 Jan; 56(2):217-28. PubMed ID: 20102401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinguishing Classical Hodgkin Lymphoma, Gray Zone Lymphoma, and Large B-cell Lymphoma: A Proposed Scoring System.
    O'Malley DP; Fedoriw Y; Weiss LM
    Appl Immunohistochem Mol Morphol; 2016 Sep; 24(8):535-40. PubMed ID: 26447896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL.
    Pilichowska M; Pittaluga S; Ferry JA; Hemminger J; Chang H; Kanakry JA; Sehn LH; Feldman T; Abramson JS; Kritharis A; Hernandez-Ilizaliturri FJ; Lossos IS; Press OW; Fenske TS; Friedberg JW; Vose JM; Blum KA; Jagadeesh D; Woda B; Gupta GK; Gascoyne RD; Jaffe ES; Evens AM
    Blood Adv; 2017 Dec; 1(26):2600-2609. PubMed ID: 29296913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Rare Case of Grey Zone Lymphoma Successfully Treated with Brentuximab Vedotin and R-CHP Chemotherapy.
    Mallipudi RM; Alquran L; Shenoy VA; Leslie LA; Conti JA
    Case Rep Oncol Med; 2019; 2019():4121234. PubMed ID: 31110830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Young patients with non-germinal center B-cell-like diffuse large B-cell lymphoma benefit from intensified chemotherapy with ACVBP plus rituximab compared with CHOP plus rituximab: analysis of data from the Groupe d'Etudes des Lymphomes de l'Adulte/lymphoma study association phase III trial LNH 03-2B.
    Molina TJ; Canioni D; Copie-Bergman C; Recher C; Brière J; Haioun C; Berger F; Fermé C; Copin MC; Casasnovas O; Thieblemont C; Petrella T; Leroy K; Salles G; Fabiani B; Morschauser F; Mounier N; Coiffier B; Jardin F; Gaulard P; Jais JP; Tilly H
    J Clin Oncol; 2014 Dec; 32(35):3996-4003. PubMed ID: 25385729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.